Since increased KLK1 promoter methylation would be predicted to decrease gene expression, this joint effect cannot explain (and indeed runs counter to) the elevated KLK1 excretion observed in our AKI cases (Figure 5). The gene discussed is KLK1; the disease is acute kidney injury.